Evidence map›Paper›PMID 25825778›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

Molecular cartography of the human skin surface in 3D.

Amina Bouslimani, Carla Porto, Christopher M Rath, Mingxun Wang, Yurong Guo, Antonio Gonzalez, Donna Berg-Lyon, Gail Ackermann, Gitte Julie Moeller Christensen, Teruaki Nakatsuji and 9 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 179 papers.

0numbers the graph read from it
0cells of the map it votes in
179citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

179 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Topographical variations in the skin barrier and their role in disease pathogenesis.Journal of the European Academy of Dermatology and Venereology : JEADV · 2025
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Skin microbiome and dermatologic disorders.The Journal of clinical investigation · 2025
    Review
  20. Article

119 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Amina BouslimaniSkaggs School of Pharmacy and Pharmaceutical Sciences.
Carla PortoSkaggs School of Pharmacy and Pharmaceutical Sciences.
Christopher M RathSkaggs School of Pharmacy and Pharmaceutical Sciences.
Mingxun WangDepartment of Computer Science and Engineering and.
Yurong GuoSchool of Medicine.
Antonio GonzalezDepartment of Chemistry and Biochemistry, BioFrontiers Institute, and.
Donna Berg-LyonDepartment of Chemistry and Biochemistry, BioFrontiers Institute, and.
Gail AckermannDepartment of Chemistry and Biochemistry, BioFrontiers Institute, and.
Gitte Julie Moeller ChristensenSkaggs School of Pharmacy and Pharmaceutical Sciences, Department of Biomedicine, Aarhus University, DK-8000 Aarhus C, Denmark;
Teruaki NakatsujiDivision of Dermatology, and Departments of.
Lingjuan ZhangDivision of Dermatology, and Departments of.
Andrew W BorkowskiDivision of Dermatology, and Departments of.
Michael J MeehanSkaggs School of Pharmacy and Pharmaceutical Sciences.
Kathleen DorresteinSkaggs School of Pharmacy and Pharmaceutical Sciences.
Richard L GalloDivision of Dermatology, and Departments of.
Nuno BandeiraSkaggs School of Pharmacy and Pharmaceutical Sciences, Department of Computer Science and Engineering and Center for Computational Mass Spectrometry, University of California, San Diego, La Jolla, CA 92093; pdorrestein@ucsd.edu bandeira@ucsd.edu robknight@ucsd.edu theodore.alexandrov@embl.de.
Rob KnightDepartment of Computer Science and Engineering and School of Medicine, Department of Chemistry and Biochemistry, BioFrontiers Institute, and Howard Hughes Medical Institute, University of Colorado at Boulder, Boulder, CO 80309; pdorrestein@ucsd.edu bandeira@ucsd.edu robknight@ucsd.edu theodore.alexandrov@embl.de.
Theodore AlexandrovSkaggs School of Pharmacy and Pharmaceutical Sciences, Center for Industrial Mathematics, University of Bremen, 28359 Bremen, Germany; SCiLS GmbH, 28359 Bremen, Germany; and European Molecular Biology Laboratory, Meyerhofstrasse 1, 69117 Heidelberg, Germany pdorrestein@ucsd.edu bandeira@ucsd.edu robknight@ucsd.edu theodore.alexandrov@embl.de.
Pieter C DorresteinSkaggs School of Pharmacy and Pharmaceutical Sciences, Biochemistry, Pharmacology, and Chemistry, University of California, San Diego, La Jolla, CA 92037; pdorrestein@ucsd.edu bandeira@ucsd.edu robknight@ucsd.edu theodore.alexandrov@embl.de.

Funding

SYNTHETIC SYSTEMSP50GM085764 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI IDEKER, TREY · 2010 to 2018
$23.3M
TrainingP41GM103484 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BANDEIRA, NUNO · 2012 to 2018
$8.7M
Cathelicidins in Skin ImmunityR01AI052453 · NIAID · VETERANS MEDICAL RESEARCH FDN/SAN DIEGO · PI GALLO, RICHARD L, NIZET, VICTOR · 2002 to 2017
$5.3M
Cathelicidin in Skin ImmunityR37AI052453 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Richard L Gallo, Victor Nizet · 2019 to 2026
$4.6M
Skin barrier function and the microbiomeR01AI116576 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GALLO, RICHARD L, NAKATSUJI, TERUAKI · 2015 to 2019
$1.7M
UCSD Dermatologist Investigator Training ProgramT32AR062496 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GALLO, RICHARD L · 2012 to 2016
$982k
Synapt ion mobility mass spectrometerS10RR029121 · NCRR · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DORRESTEIN, PIETER C · 2011 to 2011
$802k
Howard Hughes Medical InstituteNCRR NIH HHS GMS10RR029121NCRR NIH HHS S10 RR029121NIAID NIH HHS R37 AI052453NIAMS NIH HHS T32 AR062496NIGMS NIH HHS 2 P41 GM103484-06A1NIGMS NIH HHS 3-P41-GM103484NIGMS NIH HHS GM085764NIGMS NIH HHS P41 GM103484NIGMS NIH HHS P50 GM085764
6 · The paper itself

Abstract

The human skin is an organ with a surface area of 1.5-2 m(2) that provides our interface with the environment. The molecular composition of this organ is derived from host cells, microbiota, and external molecules. The chemical makeup of the skin surface is largely undefined. Here we advance the technologies needed to explore the topographical distribution of skin molecules, using 3D mapping of mass spectrometry data and microbial 16S rRNA amplicon sequences. Our 3D maps reveal that the molecular composition of skin has diverse distributions and that the composition is defined not only by skin cells and microbes but also by our daily routines, including the application of hygiene products. The technological development of these maps lays a foundation for studying the spatial relationships of human skin with hygiene, the microbiota, and environment, with potential for developing predictive models of skin phenotypes tailored to individual health.

Indexed as

Imaging, Three-DimensionalModels, BiologicalRNA, BacterialRNA, Ribosomal, 16SAdultFemaleHumansMaleMass SpectrometryMicrobiotaSkinRNA, BacterialRNA, Ribosomal, 16S16S rRNA3D mappinghuman skinmass spectrometry

Identifiers

PMID25825778
PMCPMC4418856

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.